Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of HZ-J001 cream in non-segmental vitiligo
CTR20251688Phase 2Active
- Sponsor
- Humanwell Narita Pharmaceutical
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HZ-J001 in Vitiligo, sponsored by Humanwell Narita Pharmaceutical. Started Jul 2025; status: active.
02
Drugs
HZ-J001
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20251688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251688.